Blue Jet Healthcare Ltd vs Jenburkt Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 490.7 as of 05 May 15:30 . The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 .The P/E Ratio of Jenburkt Pharmaceuticals Ltd is 0 as of March 2021 . The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Jenburkt Pharmaceuticals Ltd is ₹ 0 crore as of March 2021 . The revenue of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 205.62 crore as compare to the Sep '25 revenue of ₹ 189.75 crore. This represent the growth of 8.36% The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 44.84 crore as compare to the Sep '25 revenue of ₹ 47.64 crore. This represent the decline of -5.88% The ebitda of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 60.1 crore as compare to the Sep '25 ebitda of ₹ 79.22 crore. This represent the decline of -24.14% The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 9.24 crore as compare to the Sep '25 ebitda of ₹ 15.18 crore. This represent the decline of -39.13% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 40.17 crore over 7 quarters. This represents a CAGR of 3.57% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 7.42 crore to ₹ 5.93 crore over 7 quarters. This represents a CAGR of -12.02% The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 yearsThe Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 28.37 % on March 2021 to 24.76 % on March 2025 . This represents a CAGR of -2.69% over 5 years .

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

FAQs for the comparison of Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Jenburkt Pharmaceuticals Ltd?

Market cap of Blue Jet Healthcare Ltd is 8,263 Cr while Market cap of Jenburkt Pharmaceuticals Ltd is 459 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd?

The stock performance of Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd?

As of May 5, 2026, the Blue Jet Healthcare Ltd stock price is INR ₹476.35. On the other hand, Jenburkt Pharmaceuticals Ltd stock price is INR ₹1042.2.

How do dividend payouts of Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Jenburkt Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.